Akero Therapeutics, Inc. 10-Q, 10-Q/A, 10-QT, and 10-QT/A reports

Location
601 Gateway Boulevard, Suite 350, South San Francisco, CA
State of incorporation
DE
Fiscal year end
December 31
Data updated at
11/8/2024, 07:32 AM
Form type Sec Links Description Filing date Reporting date
10-Q Report | Data 10-Q Nov 8, 2024 Sep 30, 2024
10-Q Report | Data 10-Q Aug 9, 2024 Jun 30, 2024
10-Q Report | Data 10-Q May 10, 2024 Mar 31, 2024
10-Q Report | Data 10-Q Nov 13, 2023 Sep 30, 2023
10-Q Report | Data 10-Q Aug 11, 2023 Jun 30, 2023
10-Q Report | Data 10-Q May 15, 2023 Mar 31, 2023
10-Q Report | Data 10-Q Nov 4, 2022 Sep 30, 2022
10-Q Report | Data 10-Q Aug 5, 2022 Jun 30, 2022
10-Q Report | Data 10-Q May 6, 2022 Mar 31, 2022
10-Q Report | Data 10-Q Nov 12, 2021 Sep 30, 2021
10-Q Report | Data 10-Q Aug 13, 2021 Jun 30, 2021
10-Q Report | Data 10-Q May 13, 2021 Mar 31, 2021
10-Q Report | Data 10-Q Nov 12, 2020 Sep 30, 2020
10-Q Report | Data 10-Q Aug 12, 2020 Jun 30, 2020
10-Q Report | Data 10-Q May 13, 2020 Mar 31, 2020
10-Q Report | Data 10-Q Nov 12, 2019 Sep 30, 2019
10-Q Report | Data 10-Q Aug 12, 2019 Jun 30, 2019